GLP-1 Shortage Status: FDA List by Drug and Strength

Partly. For semaglutide injections, the shortage ended on February 21, 2025. The older Rybelsus tablets are being discontinued. Tirzepatide: Shortage resolved. On December 19, 2024, the FDA confirmed this. FDA shortage information currently leaves dulaglutide off the list; Lilly reports that every Trulicity dose can be obtained.

Shortage: Some products short
Lowest self-pay: $149 a month
Prescription: Required

Weight loss and half-life overview

Time each medicine remains in your body

Half-life in days: how long your body needs to clear half a dose, based on section 12.3 of the FDA label for each drug.

Weight lost in the main weight trial of each medicine

Percentage of body weight. Trials, doses and lengths vary, so compare each result with the placebo listed on that medicine's page.

Sources (10)

Reference list (DailyMed FDA label): 1 2 3 4 5 6 7 8 9 10.

All legitimate ways to get GLP-1, ranked

Your options for getting it, cheapest at the top
Route	Who it is for	What you pay
Ozempic: Novo Nordisk PAP	A household income no more than 200% of the federal poverty level	Free if approved
Trulicity: Lilly Cares	A household income no more than 300% of the federal poverty level	Free for up to 12 months
Ozempic: Insurance and the savings card through your doctor	Commercial insurance that covers it	As little as $25 monthly for up to 3 months
Wegovy: Insurance and the savings card through your doctor	Commercial insurance that covers it	As little as $25 a month
Mounjaro: Insurance and the savings card through your doctor	Commercial insurance that covers it	As little as $25 for a fill lasting up to 3 months
Zepbound: Insurance and the savings card through your doctor	Commercial insurance that covers it	As little as $25 for a fill lasting up to 3 months
Foundayo: Insurance and the savings card through your doctor	Commercial insurance that covers it	As little as $25 a month
Rybelsus: Insurance and the savings card through your doctor	Commercial insurance that covers it	A 1-, 2- or 3-month supply can cost as little as $25
Trulicity: Insurance and the savings card through your doctor	Commercial insurance that covers it	As little as $25 for a fill lasting up to 3 months

Prices checked November 2026. Every listed price links to the source page behind it.

Sources: Novo Nordisk pricing, NovoCare, TrumpRx, rx.costco.com.

Who qualifies

Every GLP-1 sold in the US needs a prescription. A prescriber writes it when the use is one the label approves:

Alongside diet and exercise, Ozempic helps adults with type 2 diabetes lower their blood sugar.
Ozempic reduces the chance of heart attack, stroke or heart-related death in adults with type 2 diabetes and heart disease.
Wegovy lowers heart attack and stroke risk for adults with heart disease plus obesity or overweight.
Wegovy: For adults with obesity and for adults with overweight plus a weight-related condition, it supports long-term weight loss and keeping the weight off with diet and activity. Children 12 and older who have obesity can use it too.
Mounjaro lowers blood sugar in adults and children ages 10 and older with type 2 diabetes when combined with diet and exercise.
Among adults at high risk with type 2 diabetes, Mounjaro reduces the chance of heart attack, stroke, or heart-related death.
Zepbound: For adults with obesity, or adults who are overweight and have a weight-related condition. It helps with losing weight and keeping it off over the long term, along with diet and activity.
For adults with obesity, Zepbound treats moderate to severe obstructive sleep apnea.
Foundayo: For adults with obesity, or adults who are overweight and have a weight-related condition. It helps with losing weight and keeping it off over the long term, along with diet and activity.
For adults who have type 2 diabetes, Rybelsus helps lower blood sugar alongside diet and exercise.
In high-risk adults with type 2 diabetes, Rybelsus reduces the chance of heart attack, stroke, or heart-related death.
Trulicity: Used with diet and exercise, it brings blood sugar down for people with type 2 diabetes who are adults or children 10 and older.
Adults with type 2 diabetes show lower heart-related risks with Trulicity if heart disease or multiple heart risk factors are present. These risks include heart attack, stroke, and heart-related death.
Saxenda: For adults with obesity and for adults with overweight plus a weight-related condition, it supports long-term weight loss and keeping the weight off with diet and activity. Children 12 and older who weigh over 60 kg and have obesity can use it too.
Victoza lowers blood sugar in adults and children 10 years and older who have type 2 diabetes, when used with diet and exercise.
Adults with type 2 diabetes plus heart disease who take Victoza face a lower risk of heart attack, stroke, or heart-related death.

Source: FDA label (DailyMed).

Telehealth choices compared

Telehealth programs for GLP-1
Program	Medicine option	Medicine price	Membership	All in
WeightWatchers Med+	Foundayo pill (self-pay)	$149 a month	$74 a month	$223 a month
WeightWatchers Med+	Wegovy pill (self-pay)	$149 a month	$74 a month	$223 a month
WeightWatchers Med+	Ozempic injectable pen (self-pay)	$199 a month	$74 a month	$273 a month
Ro	Wegovy pill, starting dose	$149 a month	$149 a month	$298 a month
Ro	Foundayo pill, starting dose	$149 a month	$149 a month	$298 a month
Hims & Hers	Wegovy pill	$149 a month	$149 a month after first month	$298 a month
Hims & Hers	Ozempic pen	$199 a month	$149 a month after first month	$348 a month
WeightWatchers Med+	Zepbound (self-pay)	$299 a month	$74 a month	$373 a month
Sesame (Success by Sesame)	Wegovy or Ozempic pen, after intro months	$349 a month	$59 a month	$408 a month
Ro	Zepbound KwikPen, starting dose	$299 a month	$149 a month	$448 a month
Ro	Wegovy pen, 1 mg to 2.4 mg	$349 a month	$149 a month	$498 a month
Hims & Hers	Zepbound	$1,899 a month	$149 a month after first month	$2,048 a month
Hims & Hers	Mounjaro	$1,899 a month	$149 a month after first month	$2,048 a month
Mochi Health	Compounded semaglutide (not FDA approved)	$60 a month	$79 a month after free first month	$139 a month
Mochi Health	Compounded tirzepatide (not FDA approved)	$90 a month	$79 a month after free first month	$169 a month
Henry Meds	Compounded liraglutide (daily injection) (not FDA approved)	$179 a month	Not listed	Included
Henry Meds	Compounded semaglutide taken under the tongue as tablets or drops (not FDA approved)	$179 a month	Not listed	Included
Noom Med	Microdose GLP-1Rx Program (compounded) (not FDA approved)	starting after 4 weeks, the monthly price is $179 with quarterly billing	Not listed	Included
Noom Med	GLP-1Rx Program (compounded semaglutide) (not FDA approved)	starting after 4 weeks, the monthly price is $249 with quarterly billing	Not listed	Included
Found	Compounded GLP-1 plan (not FDA approved)	$99 a month	$169 a month cash	$268 a month
Henry Meds	Compounded semaglutide (weekly injection) (not FDA approved)	$297 a month	Not listed	Included
Noom Med	GLP-1Rx Plus Program: compounded GLP-1 and GIP, with no FDA approval	starting after 4 weeks, the monthly price is $299 with quarterly billing	Not listed	Included

The prices come from the pricing page each program posts. No money comes to us from any of them.

Programs that bill for medicine through insurance or a pharmacy
Program	Membership	Type
Calibrate	$199 a month	insurance-first
PlushCare	$19.99 a month	primary care membership
Hello Alpha	$79 a month	brand only

Sources: weightwatchers.com, ro.co, hims.com, sesamecare.com.

Shortage status

For semaglutide injections, the shortage ended on February 21, 2025. The older Rybelsus tablets are being discontinued.

Product-by-product semaglutide supply
Product	FDA status	Availability
Rybelsus tablet 3 mg, 7 mg, 14 mg	To Be Discontinued	Replaced by Ozempic (semaglutide) tablets

The FDA shortage list first included it in March 2022
Shortage resolved: February 21, 2025
Compounded copy production at state pharmacies had to end on April 22, 2025
On May 22, 2025, outsourcing facilities had to stop

Tirzepatide: Shortage resolved. On December 19, 2024, the FDA confirmed this.

Its first listing on the FDA shortage list was December 15, 2022
Shortage resolved: December 19, 2024
State pharmacies had to end compounded copy production on February 18, 2025
On March 19, 2025, outsourcing facilities had to stop

FDA shortage information currently leaves dulaglutide off the list; Lilly reports that every Trulicity dose can be obtained.

Liraglutide: The current shortage list still names it. Availability for Victoza pens is limited; generics are available; Saxenda is set to be discontinued in January 2027.

Liraglutide supply, product by product
Product	FDA status	Availability
Victoza 6 mg/mL pen (2-pack and 3-pack)	Current	Limited Availability
Victoza back order	Current	Back order
Saxenda 6 mg/mL pen (5-pack)	To Be Discontinued	Available until January 2027
Generic liraglutide (Meitheal, Teva)	Current	Available

The FDA shortage list first included it on July 18, 2023

Sources: FDA, api.fda.gov, ashp.org.

Scam signals

No prescription needed: sellers who skip the prescription are not licensed US pharmacies.
Well below the price the manufacturer charges for a brand: paying on your own, the lowest cost for that brand comes to $149 a month.
Compounded drugs sold as the brand: they lack FDA approval, so Ozempic, Wegovy, Mounjaro and Zepbound are not among them.
According to the source, semaglutide acetate and semaglutide sodium are salt forms, and they are not the active ingredient found in approved drugs.
The FDA issued 30 warning letters to telehealth companies over misleading claims that their products were the same as the brand.
Harm reports: Compounded semaglutide is linked to 990 FDA adverse event reports.
Harm reports: Compounded tirzepatide is linked to more than 730 FDA adverse event reports.
A price per month with no drug included: one program faced FTC action for this; see NextMed review.

Sources: Novo Nordisk pricing, NovoCare, TrumpRx, rx.costco.com.

Find it in your state

Hims & Hers: Service does not reach all 50 states
Noom Med: Offered in fewer than all 50 states
NovoCare Pharmacy: Its delivery network reaches all 50 states, DC, Puerto Rico

Which route you take depends most on Medicaid rules. nothing shapes your route more than Medicaid rules. Right now, 10 state Medicaid programs cover GLP-1s for weight loss. Select your state to view its drug list and prior authorization rules:

Sources: hims.com, noom.com, NovoCare.